Naveen Pathak
Advertisement
Naveen Pathak is a principal engineer in the process development department at Amgen, Inc.
Articles by Naveen Pathak
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on BioPharm International
1
BioPharm Brief: Gene Therapy Progress, FDA Approval, and $103M Funding
2
FDA Approves Roche’s Enspryng as First At-Home Subcutaneous Treatment for Thyroid Eye Disease
3
Estuary Biotherapeutics Launches With $103 Million for ADPKD Gene Therapy
4
Opus Genetics’ OPGx-LCA5 Gene Therapy Shows Sustained Vision Gains Ahead of Phase 3
5

